Tucatin 150 mg (Tucatinib) Tablets

Tucatinib 150 mg is a targeted anticancer medicine used to treat HER2-positive breast cancer. It works by selectively inhibiting HER2 signaling pathways that promote cancer cell growth and spread. When used in combination with other anticancer therapies, it helps slow disease progression and may improve treatment outcomes in eligible patients.

Therapeutic Effects:

• Helps inhibit the growth of HER2-positive cancer cells
• Supports the management of advanced and metastatic breast cancer
• May reduce tumor progression in patients previously treated with anti-HER2 therapies
• Assists in controlling the spread of cancer to other parts of the body
• Provides targeted treatment with a focus on HER2-driven malignancies
• Commonly used as part of combination therapy under oncology specialist supervision

Active Ingredient:
Tucatinib INN 150 mg

Composition:
Each film-coated tablet contains Tucatinib 150 mg as the active pharmaceutical ingredient. Tucatinib is a highly selective tyrosine kinase inhibitor designed to target the HER2 receptor and interfere with signaling pathways involved in cancer cell proliferation and survival.

Always use this medicine exactly as prescribed by a qualified healthcare professional. Treatment should be initiated and monitored by an experienced oncology specialist.

Recommended Adult Dose:

• The usual recommended dose is 300 mg orally twice daily (equivalent to two 150 mg tablets per dose).
• Administer approximately 12 hours apart or as directed by the treating physician.

Administration Guidelines:

• Swallow tablets whole with water.
• Can be taken with or without food.
• Do not crush, split, or chew the tablets unless advised by a healthcare professional.
• Continue treatment for as long as clinically indicated or until disease progression or unacceptable toxicity occurs.

Missed Dose:

• If a dose is missed, skip the missed dose and take the next scheduled dose at the usual time.
• Do not take a double dose to make up for a forgotten dose.

Important Instructions:

• Regular monitoring of liver function and treatment response may be required.
• Follow all medical advice regarding combination therapy and supportive care.
• Inform your healthcare provider about all medications and supplements you are taking before starting treatment.
• Dose adjustments may be necessary based on individual tolerance and adverse reactions.